Ignite Creation Date:
2024-05-06 @ 7:51 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06161571
Status:
RECRUITING
Last Update Posted:
2024-07-01
First Post:
2023-11-22
Brief Title:
A Study Evaluating Efruxifermin in Subjects with Non-invasively Diagnosed Nonalcoholic Steatohepatitis NASHMetabolic Dysfunction-Associated Steatohepatitis MASH and Nonalcoholic Fatty Liver Disease NAFLDMetabolic Dysfunction-Associated Steatotic Liver Disease MASLD
Sponsor:
Akero Therapeutics Inc
Organization:
Akero Therapeutics Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-11-10
Start Date Type:
ACTUAL
Primary Completion Date:
2026-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-10
Completion Date Type:
ESTIMATED
First Submit Date:
2023-11-22
First Submit QC Date:
November 29 2023
Study First Post Date:
2023-12-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-03
Last Update Post Date:
2024-07-01
Last Update Post Date Type:
ACTUAL